360biolabs is a contract service organisation providing specialist expertise and laboratory services for the development of new therapeutics, vaccines and diagnostics in a quality-assured environment.
- Diverse range of assays and biomarker endpoints for clinical trials and preclinical studies in many therapeutic areas
- Particular expertise in virology, immunology and analytical chemistry
- World-class facilities with BSL-2, BSL-3 & quarantine laboratories
- Quality management systems (ISO / IEC 17025 & 15189 and OECD Principles of GLP) to ensure that “every sample counts”
- Scalable capabilities from research to late stage clinical trials
- Highly experienced in the design, optimisation and validation of assays with industry standard and regulator compliant reporting
- Proven track record of working with leading pharmaceutical and biotech companies, universities and institutes
About 360biolabs
Company size
11-50 people
Founded in
2015
Markets
